Device Trial Radar · NCT07057206
Simultaneous Engagement of Networks for Alleviating Pain (SENAP)
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
20
Planned (sponsor's estimate)
Start
Jan 1, 2027
Primary completion
Dec 2030
Study completion Dec 2030
Sponsor
- Lead sponsor
- University of MinnesotaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 9, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial is investigating the acceptability and efficacy of PFM-guided cortical stimulation for the treatment of central neuropathic pain.
Conditions
- Neuropathic Pain
- Postherpetic Neuralgia
Interventions
PFM-guided cortical stimulationDevice
Abbott Eterna IPG and Lamitrode 44 paddles with accessory extensions and clinical programmers
Primary outcomes
What the sponsor says the trial is designed to measure.
- FeasibilityTime frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Minnesota
Minneapolis, Minnesota
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.